). We isolated UFD2 in a tor from its activation in the cytosol to its final degradabiochemical screen and showed that it binds ubiquitin tion and also mediates proteolysis at the endoplasmic conjugates and CDC48 (Koegl et al., 1999). Notably, reticulum by the ERAD pathway.
Binding by UFD2 enzyme UFD2, and finally bound by RAD23/DSK2 for Next we asked how UFD2 receives oligoubiquitylated proteasomal targeting. Intriguingly, the multiubiquitin substrates for multiubiquitylation. A clue to this question chains catalyzed by E4 at the CDC48 UFD1/NPL4 complex came from our previous studies showing that UFD2 are restricted in size but sufficiently long enough for binds CDC48 (Koegl et al., 1999). Because CDC48 uses RAD23/DSK2 binding. All factors of this pathway bind UFD1 and NPL4 as cofactors, we investigated their relaubiquitin conjugates and make contacts with their retionship to UFD2. Notably, binding of UFD2 to CDC48 spective upstream or downstream acting factors. We in vivo was reduced both in ufd1-2 and npl4-1 temperashow that this escort pathway controls activation and ture-sensitive mutants (Figure 2A ), suggesting that degradation of the NFB-related yeast transcription fac-UFD2-CDC48 interaction is stimulated by the UFD1/ tor SPT23 and that it is involved in ER-associated degra-NPL4 cofactors. CDC48 can interact with ubiquitylated dation (ERAD).
substrates directly (Rape et al., 2001 ), but association of ubiquitin conjugates with CDC48 in vivo is reduced in both ufd1-2 and npl4-1 mutant cells ( Figure 2B and Results see Supplemental Figure S2 on the Cell website). These results suggest that ubiquitylated substrates are primar-E4 Multiubiquitylation Activity ily recruited to the CDC48 complex via the cofactors To investigate the functional relationship between novel UFD1/NPL4 in vivo. proteolytic factors, we took advantage of artificial ubiBased on this finding, we then asked whether the quitin-fusion proteins as model substrates (UFD pathassociation of UFD2 with ubiquitylated substrates is also way). These proteins are already primed for degradation stimulated by the substrate-recruiting cofactors of due to the presence of their ubiquitin domains (Johnson CDC48 we found that UFD2 bound Ubi-GST weakly ( Figure 2E ), The yeast E4 enzyme UFD2 is the founding member but when CDC48 UFD1/NPL4 was added to the sample, bindof so-called U-box proteins (Koegl et al., 1999). Because ing of UFD2 to Ubi-GST was strongly stimulated. the U-box is structurally similar to the RING fingers of CDC48 is known to localize both to the cytosol and certain E3 ubiquitin ligases (Aravind and Koonin, 2000; the nucleus, and it may shuttle between these compartOhi et al., 2003), we asked for the role of this domain in ments (Madeo et al., 1998). Interestingly, UFD2 is pre-UFD2. The assay we used is a fully defined in vitro dominantly concentrated in the nucleus but is signifiubiquitylation system using E1, E2, and E3 enzymes and cantly relocated to the cytoplasm in cdc48-6 or ufd1-2 the fusion protein ubiquitin-protein A (Ubi-ProtA) as a mutant cells (see Supplemental Figure S3 ). This result substrate (Koegl et al., 1999). When we deleted the suggests that nuclear localization of UFD2 is mediated C-terminal U-box (UFD2 ⌬U-box ), the protein was devoid in part by the CDC48 UFD1/NPL4 machinery. of E4 activity ( Figure 1A) . The U-box was also required in vivo, as indicated by the complete stabilization of the CDC48 UFD1/NPL4 Restricts otherwise short-lived UFD substrate ubiquitin-prolineMultiubiquitin Chain Assembly ␤-galactosidase (Ubi-Pro␤gal; Johnson et al., 1995) in
The finding that the E4 enzyme collects its substrates a ufd2 ⌬U-box mutant strain ( Figure 1B) . Furthermore, simivia the CDC48 UFD1/NPL4 complex prompted us to study lar to RING fingers (Weissman, 2000) , the U-box could multiubiquitylation in vitro in the presence of the chapercatalyze "autoubiquitylation" (i.e., ubiquitylation of the one-like complex. By using three different model sub-U-box protein by E1 and E2) (see Supplemental Figure  strates (Ubi-ProtA, Ubi-GST, and Ubi-Pro␤gal), we found S1 at http://www.cell.com/cgi/content/full/120/1/73/ that the size of E4-catalyzed multiubiquitin chains was reduced by the activity of the CDC48 complex ( Figures  DC1/) . Because UFD2 recognizes the ubiquitin moieties (A) The U-box is required but not sufficient for E4 activity of UFD2 in vitro. UFD2, UFD2 ⌬U-box , and GST-U-box were added to an in vitro ubiquitylation reaction of the substrate UbiProtA containing E1, E2, and E3. Only wt but not UFD2 ⌬U-box or GST-U-Box possesses E4 activity. Proteins were detected by anti-protein A immunoblotting. (B) The U-box is essential for degradation of Ubi-Pro␤gal in vivo. Degradation of Ubi-Pro␤gal was studied by pulse-chase experiments in wt, ⌬ufd2, and cells expressing UFD2 ⌬U-box (ufd2 ⌬U-box ) followed by autoradiography. The asterisk marks a characteristic degradation product of Ubi-Pro␤gal.
3A-3C
). This effect was dose dependent and mediated assays using purified proteins showed that both RAD23 by the CDC48 protein but apparently not by its cofactors and DSK2 but not RPN10 binds UFD2 directly and effi-( Figure 3D ). It was specific for CDC48, as even a large ciently ( Figure 4A ). However, in contrast to UFD1/NPL4 excess of BSA did not cause a similar reduction (Figure and UFD2, the receptor proteins RAD23 and DSK2 (and 3A). CDC48 selectively inhibited the formation of very RPN10) are apparently not cofactors of CDC48, as no long E4-catalyzed chains, thereby restricting the majordirect interaction could be detected ( Figure 4B ). Howity of multiubiquitin chains to an average of three to six ever, we found that UFD2 can bind CDC48 and RAD23 ubiquitin moieties (termed "size-restricted chains" in the simultaneously, forming a ternary complex ( Figure 4C ). following). Importantly, CDC48 did not completely preBecause the association of CDC48 with RAD23 was vent E4 activity, as the size-restricted chains contained apparently bridged by UFD2, CDC48 associated with in general at least one to three more ubiquitin moieties RAD23 in vivo and in cell extracts significantly weaker than chains assembled in the absence of E4 (Figures than with its cofactors UFD1/NPL4 and UFD2 ( Figures  1A and 3A-3C and Koegl et al. [1999] ). Moreover, the 4D and 4E). Mapping assays showed that RAD23 binds inhibitory effect could not be reverted by subsequent to an N-terminal region of UFD2, whereas CDC48 binds addition of a surplus of E4 to the reaction ( Figure 3E) , to a different domain of UFD2, which is proximal to the indicating that size restriction is not caused by E4 titra-C-terminal U-box ( Figure 4F ). Interestingly, UFD2 binds tion or a simple inactivation mechanism.
to a C-terminal region of CDC48 ( Figure 4G) We noticed that ⌬ufd2 mutants are strongly hypersensitive to oleic acid ( Figure 6A ). Similar phenotypes were observed with the ⌬rad23 ⌬dsk2 double mutant and, somehow weaker, with the ⌬rpn10 mutant. These findings suggest that the OLE pathway is hyperactive in these mutants and that any further addition of oleic acid to cells causes slow growth. Importantly, ⌬ufd2 and ⌬rad23 mutants exhibit an epistatic relationship (i.e., the ⌬ufd2 ⌬rad23 double mutant has a similar phenotype as the ⌬ufd2 single mutant), indicating that UFD2 and RAD23 function in the same pathway. In contrast, UFD2 and RPN10 seem to function in parallel pathways, as the double mutant is much more sensitive than either single mutants ( Figure 6A ). SPT23 processing occurs normally in all these mutants ( Figure 6B ), demonstrating that the respective facmyc antibodies, and bound VSV CDC48 was detected by anti-VSV immunoblots. The amount of coprecipitated VSV CDC48 is reduced in ufd1-2 and npl4-1 mutant cells compared to wt. Cells were shifted to the restrictive temperature of ufd1-2 and npl4-1 (37ЊC) for 2 hr, and growth was supported by oleic acid in the medium ( lanes 1-5) . Subsequently, the concentration of UFD2 was stepwise increased to approximately 3 M (lanes 6-9). The reaction products were analyzed by anti-ProtA immunoblots.
tors do not mediate SPT23 activation. However, we obin the ⌬rad23 single mutant but strongly in the ⌬rad23 ⌬dsk2 double mutant, emphasizing their overlapping served that p90, the processed, monoubiquitylated form of SPT23, which is short-lived in wt cells (Hoppe et al., activities. Notably, the strength of p90 stabilization in the mutants correlates well with their oleic acid hyper-2000), was partially stabilized in the ⌬ufd2 mutant. This indicates that E4 activity is important for p90 breaksensitivities ( Figure 6A) . Moreover, the comparatively mild phenotypes of ⌬rpn10 mutants also draw a parallel down, and, indeed, UFD2 binds p90 in vivo (Supplemental Figure S1C ). The ⌬rpn10 single mutant stabilized to the limited ability of RPN10 to bind size-restricted multiubiquitin chains ( Figure 5A ). By using alleles that p90 only weakly, but the ⌬ufd2 ⌬rpn10 double mutant stabilized p90 very strongly ( Figure 6B ). This behavior still allow significant SPT23 processing at the restrictive temperature, we also found that the turnover of p90 suggests that UFD2 and RPN10 function mainly in parallel p90 degradation pathways and that both pathways strictly depends on the ubiquitin ligase RSP5 (rsp5-1) and the proteasome (cim3-1) ( Figure 6B, bottom panel) . must be blocked in order to get a nearly complete stabilization. Similarly, SPT23 p90 was only weakly stabilized
In conclusion, these data suggest a model in which moderately in the respective single mutants. Notably, To investigate whether the proteins that act downDeg1 SEC62 was only marginally more stabilized in a ⌬ufd2 stream of CDC48 in the UFD and OLE pathways are also ⌬rad23 double mutant than in a ⌬ufd2 single mutant, involved in ERAD, we followed the turnover of typical substantiating the finding that UFD2 and RAD23 function in the same pathway. Together, these data demon-ERAD substrates in the respective mutants. Indeed, we a few extra ubiquitin moieties (size-restricted chains) . Subsequently, UFD2 recruits RAD23 (or DSK2; blue), which binds the ubiquitin-protein conjugate and delivers it to the proteasome for degradation. See text for details. strate that, in addition to the CDC48 UFD1/NPL4 chaperone, Multiubiquitin Chain Size Restriction Unexpected was the observation that the multiubiquitin the downstream-acting factors UFD2, RAD23, and DSK2 chains catalyzed by E4 in the presence of CDC48 were also contribute to ERAD pathways. Moreover, our findrelatively short, harboring as few as three to six ubiquitin ings also indicate that UFD2-and RPN10-dependent moieties. The significance of this finding became apparpathways are partially redundant. ent when we realized that these chains nevertheless contain sufficient ubiquitin moieties that are adequate, if not optimal (Raasi et al., 2004), for being recognized Discussion by RAD23 and DSK2. Most importantly, without E4 activity, the chains are too short (one to two ubiquitin moieAn Escort Pathway to the Proteasome ties) for RAD23/DSK2 binding. Thus, E4 is a crucial In this work, we describe a pathway in which ubiquitin switch, which triggers degradation by adding just one conjugates are escorted to the proteasome by a succesto two ubiquitin moieties to the conjugate. RAD23 and sion of interacting factors. Strikingly, all escort factors DSK2 act at the end of the cascade as they bind both E4 involved are ubiquitin binding proteins. In our model of (UFD2) and proteasomes. In contrast, the proteasomal this pathway (Figure 7) , oligoubiquitylated substrates ubiquitin receptor RPN10 does not bind UFD2 and has are first recognized by the substrate-recruiting cofacno significant affinity for size-restricted chains. Even tors of CDC48, relocated onto the bound E4 enzyme for so, RPN10 contributes to p90 degradation and ERAD, multiubiquitylation, and subsequently handed over to suggesting that a few substrates can escape size re-RAD23/DSK2 for proteasomal targeting and degradastriction (or are multiubiquitylated without a requirement tion. Central to this pathway is CDC48, which is posifor UFD2) and are targeted to proteasomes via an altertioned strategically as it connects substrate recruitment native RPN10-dependent route. with multiubiquitylation and proteasomal targeting. This How the CDC48 complex might accomplish size rering-shaped enzyme is thought to undergo ATP-depenstriction of multiubiquitin chains is currently unclear. An dent movements by which the enzyme can take protein intriguing possibility is that the putative six ubiquitin complexes apart (Rouiller et al., 2002) . CDC48 may thus binding sites on the hexameric CDC48 enzyme might function similar to the related AAA-ATPase NSF (SEC18), help to coordinate and limit chain formation. On the which disassembles SNARE bundles (Brunger and Deother hand, size restriction could be a common activity LaBarre, 2003). The handiness of having such an activity of several ubiquitin binding proteins. RAD23 was reearly in a proteolytic pathway becomes particularly eviported to inhibit multiubiquitylation in vitro, and it has dent for the OLE and ERAD pathways. In the OLE pathbeen suggested that it thereby prevents degradation way, this activity is employed to segregate the pro- (Ortolan et al., 2000) . However, RAD23 can still bind the cessed, monoubiquitylated SPT23 transcription factor generated short chains, and thus we rather argue that it from its uncleaved partner molecule at the ER memdoes not function as an inhibitor but that it may possess brane. For ERAD, the CDC48 machinery is thought to ubiquitin chain size-restriction activity as well. A remobilize ubiquitylated ERAD substrates from the ER duced number of ubiquitin moieties in a chain to a size channel. Generalizing from these two cases, we postuthat is still sufficient for proteasomal targeting would late that CDC48 might be able to selectively remove a not only be economical but would also ease ubiquitin particular protein from a protein complex. If coupled to chain disassembly. Moreover, we propose that size rea proteasomal pathway, this activity would permit the striction might also prevent undesired side reactions of selective elimination of a single subunit of an oligomeric ubiquitin chain formation, such as tree-like, branched protein complex.
modifications that arise if more than one lysine residue It is interesting to note that the OLE and UFD pathways of a ubiquitin moiety is used for chain formation. In fact, share many components. Furthermore, similar to SPT23 one might even entertain the dissenting idea that heavily p90, also the UFD substrate Ubi-Pro␤gal is predomiubiquitylated substrates that accumulate to detectable nantly a nuclear protein, and its nuclear localization delevels in vivo are precisely those that are less compatible pends on the activity of the CDC48 UFD1/NPL4 complex (Supwith proteasomal degradation. plemental Figure S4) 
